Lexicon Pharmaceuticals, Inc.
Ticker: LXRX
| Insider | Title |
|---|---|
| Administratiekantoor Westend Stichting | Director, 10% or greater ownership |
| Advisors, L.l.c. Invus | Director, 10% or greater ownership |
| Alan J Main | EVP, Innov Chem Sciences |
| Alan S Nies | Director |
| Amaury Wittouck | Director, 10% or greater ownership |
| Brian Corrigan | SVP, Regulatory QA |
| Brian T Crum | SVP, General Counsel Secr. |
| Christopher J Sobecki | Director |
| Craig B Granowitz | SVP, Chief Medical Officer |
| Diane E. Sullivan | Director |
| Frank Palantoni | Director |
| Global Management, Llc Invus | Director, 10% or greater ownership |
| Group S.a. Artal | Director, 10% or greater ownership |
| International Management S.a. Artal | Director, 10% or greater ownership |
| International S.c.a. Artal | Director, 10% or greater ownership |
| Jeffrey L Wade | President and COO |
| Judith L Swain | Director |
| Kenneth B. Kassler-taub | SVP, Regulatory QA |
| Kiernan Seth | VP, Chief Commercial Officer |
| Kristen Alexander | VP, Finance and Accounting |
| L.l.c. Siren, | Director, 10% or greater ownership |
| L.l.c. Ulys, | Director, 10% or greater ownership |
| L.p. Invus, | Director, 10% or greater ownership |
| Lisa Defrancesco | VP, IR and Corp Strategy |
| Lonnel Coats | Chief Executive Officer, Director |
| Michael Exton | Chief Executive Officer, Director |
| Philippe Amouyal | Director |
| Public Equities Advisors, Llc Invus | Director, 10% or greater ownership |
| Public Equities, L.p. Invus | Director, 10% or greater ownership |
| Raymond Debbane | Director |
| Robert J Md Lefkowitz | Director |
| S.a. Westend | Director, 10% or greater ownership |
| Sam L Barker | Director |
| Thomas Garner | SVP, Chief Commercial Officer |
| Us Partners Llc Invus | Director, 10% or greater ownership |
| Wendy Mcdermott | VP, Human Resources |